Abstract
Nuclear hormone receptors (NHRs) are transcription factors that bind to lipophilic signaling molecules (ligands), and subsequently regulate the expression of target genes. Since NHR ligands have potential as therapeutic agents, one of the most active research areas in the NHR field is the synthesis and identification of small molecule ligands for NHRs. Wipf et al. have recently reported the creation of a discovery library using a new method for the synthesis of homoallylic amides, allylic amides and C-cyclopropylalkylamides. This article is intended to review the use of this discovery library to screen for activators for the pregnane X receptor (PXR), a master xenobiotic receptor that regulates the expression of Phase I and Phase II enzymes as well as drug transporters. Our screening of the discovery library identified potent PXR activators whose carbon scaffolds are distinct from the chemical structures of known PXR agonists. Moreover, we found that enantiomers of the same compound show a species-specific activation of PXR. The development of the discovery library and the implications of enantiospecificity of PXR ligand design represent the primary focus of this account.
Keywords: Nuclear hormone receptors, gene expression, small molecule modulators, peptide mimetics, PXR, pregnane X receptor, enantiospecific binding, species specificity, discovery library screening
Mini-Reviews in Medicinal Chemistry
Title: New Opportunities for Pregnane X Receptor (PXR) Targeting in Drug Development. Lessons from Enantio- and Species-Specific PXR Ligands Identified from A Discovery Library of Amino Acid Analogues
Volume: 7 Issue: 6
Author(s): Peter Wipf, Haibiao Gong, Jelena M. Janjic, Song Li, Billy W. Day and Wen Xie
Affiliation:
Keywords: Nuclear hormone receptors, gene expression, small molecule modulators, peptide mimetics, PXR, pregnane X receptor, enantiospecific binding, species specificity, discovery library screening
Abstract: Nuclear hormone receptors (NHRs) are transcription factors that bind to lipophilic signaling molecules (ligands), and subsequently regulate the expression of target genes. Since NHR ligands have potential as therapeutic agents, one of the most active research areas in the NHR field is the synthesis and identification of small molecule ligands for NHRs. Wipf et al. have recently reported the creation of a discovery library using a new method for the synthesis of homoallylic amides, allylic amides and C-cyclopropylalkylamides. This article is intended to review the use of this discovery library to screen for activators for the pregnane X receptor (PXR), a master xenobiotic receptor that regulates the expression of Phase I and Phase II enzymes as well as drug transporters. Our screening of the discovery library identified potent PXR activators whose carbon scaffolds are distinct from the chemical structures of known PXR agonists. Moreover, we found that enantiomers of the same compound show a species-specific activation of PXR. The development of the discovery library and the implications of enantiospecificity of PXR ligand design represent the primary focus of this account.
Export Options
About this article
Cite this article as:
Peter Wipf , Haibiao Gong , Jelena M. Janjic , Song Li , Billy W. Day and Wen Xie , New Opportunities for Pregnane X Receptor (PXR) Targeting in Drug Development. Lessons from Enantio- and Species-Specific PXR Ligands Identified from A Discovery Library of Amino Acid Analogues, Mini-Reviews in Medicinal Chemistry 2007; 7 (6) . https://dx.doi.org/10.2174/138955707780859404
DOI https://dx.doi.org/10.2174/138955707780859404 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Apoptosis Suppression by Candidate Oncogene PLAC8 is Reversed in Other Cell Types
Current Cancer Drug Targets Mass Spectrometry Data Analysis in the Proteomics Era
Current Bioinformatics TRP Channels as A Newly Emerging Non-Voltage-Gated Ca2+ Entry Channel Superfamily
Current Pharmaceutical Design Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer
Current Medicinal Chemistry Targeting the EGFR Pathway for Cancer Therapy
Current Medicinal Chemistry A Novel Bromomelatonin Derivative Suppresses Apoptosis with Regulating the Expression of Bcl-2 Family Genes
Letters in Drug Design & Discovery Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues
Anti-Cancer Agents in Medicinal Chemistry Influence of Pulsing Electromagnetic Field Therapy on Gene Expression in Muscle Cells, Peripheral Circulation, and Metabolic Factors in Aging Adults
Current Chemical Biology Current Inhibitors of Checkpoint Kinase 2
Current Medicinal Chemistry In Silico Studies towards Enhancing the Anticancer Activity of Phytochemical Phloretin Against Cancer Drug Targets
Current Drug Therapy Antimicrobial Peptides Present in Mammalian Skin and Gut are Multifunctional Defence Molecules
Current Pharmaceutical Design Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I
Current Neuropharmacology Effects of Somatostatin and Vitamin C on the Fatty Acid Profile of Breast Cancer Cell Membranes
Anti-Cancer Agents in Medicinal Chemistry Inhibitors of the Sphingosine Kinase Pathway as Potential Therapeutics
Current Cancer Drug Targets Development of Steroidal Aromatase Inhibitors as Potential Anti-breast Cancer Agents
Current Enzyme Inhibition Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer
Current Protein & Peptide Science Further Vitamin D Analogs
Current Vascular Pharmacology Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Current Pharmaceutical Design IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
Current Rheumatology Reviews Cytostatic and Cytotoxic Activity of Synthetic Diterpene Derivatives Obtained from (-)-Kaur-9(11), 16-Dien-19-Oic Acid Against Human Cancer Cell Lines
Letters in Drug Design & Discovery